Contract Research Organization
Benchmarking Your Pharmaceutical Contract Manufacturing Strategies in 2013
March 13 by Pharma IQ SurveysAs a thank you, all participants who complete the survey by 28th March are automatically entered in a prize draw for a free place at Pharma IQ’s 6th Annual Global Pharma Contract Manufacturing...
Pharma IQ Talking Heads - Global Pharmaceutical Contract Manufacturing Roundtable 2012
February 16 by Pharmaceuticals & Biotechnology EditorContract Manufacturing in Pharmaceuticals continues to increase… Decreasing profits in pharmaceuticals over the past 5 years has put manufacturing and product costs under greater scrutiny....
Pharmaceutical Outsourcing, Where Do You Draw the Line?
May 20 by Cristina FalcãoThe real issue in pharma is budget and structural change. There are no magic methods to overcome what Richard Nelson called "the simple economics of basic scientific research—patents or no patents, ca...
Choosing a New CMO? The Cost of Change is Critical
May 03 by Andrea CharlesRichard Loughlin, Director, Contract Manufacturing Business Development North America, Commercial & External Partnerships (CEPiA) sanofi aventis, joins Andrea Charles from Pharma IQ, to discuss&...
Unlocking the Value of Strategic Partnerships with CRO’s and Pharmaceutical Companies in Asia
March 02 by Frank FloetherIntroduction Considering potential benefits and the impact of pitfalls of any Asian offshoring ambitions you need to analyse your situation and intentions first to establish the right base to unl...
Is Your Clinical Outsourcing Clear?
February 22 by Pharma IQIn the pharmaceutical industry, the majority of companies now outsource the clinical trial process, with a massive 67 per cent of pharma and bio organisations outsourcing more than half of their tri...
Why Are We Going to Move to Another CRO?
February 14 by Richard de Silva[inlinead] Antonio Llamas, Regional Head of Operations in Spain and Portugal for Wyeth Research, joins Pharma IQ, to discuss global clinical outsourcing. To listen to the podcast go to Strategies...
Logistics for Clinical Trials in Emerging Markets
August 19 by Pharma IQMark Walls, Director of Clinical Pharmacy at Human Genome Sciences, speaks to Andrea Charles from Pharma IQ, about the logistical challenges facing clinical trials and avoiding common mistakes for log...
India Looks to a Future in Clinical Trials
July 30 by Pharma IQIf the recent recession highlighted anything to firms in all sectors, it was how important it is for them to focus on their core competencies. On occasion, companies can be led away from their prima...
Best Practice Tips for Overcoming Obstacles in Biomarker Development
July 29 by Pharma IQHow can we overcome the latest challenges in Biomarker Development? Birgitte Søgaard, Divisional Director for Clinical Pharmacology and Translational Medicine at H Lundbeck A/S, discusses wit...
FDA Concerned About Lack of PI Oversight in Early Phase Clinical Trials
April 20 by Andrea CharlesIn part one of this interview Dan Sfera from The Clinical Trials Guru, speaks to Andrea Charles from Pharma IQ, about the big trends making an impact in clinical research, the FDA'...